{"title":"Dissociation between M1-facilitation of acetylcholine release and crosstalk with A2A- and M2-receptors on rat motoneurons","authors":"Laura Oliveira, P. Correia-de-Sá","doi":"10.1002/SITA.200500057","DOIUrl":null,"url":null,"abstract":"Acetylcholine (ACh) facilitates its own release acting at muscarinic M1 receptors on rat motoneurons. While the M1 positive feedback mechanism is operative there is a concomitant suppression of the ability of muscarinic M2-inhibitory and adenosine A2A-facilitatory receptors to control [3H]ACh release. We aimed at investigating whether M1-occlusion of M2 and A2A receptors function could result from interplay at second messengers level. Drugs blocking the IP3 pathway, like LiCl and 2-aminoethoxydiphenylborane (2-APB), but not the selective PKC inhibitor, chelerythrine, attenuated M1 facilitation by McN-A-343. PKC activation with phorbol 12-myristate 13-acetate mimicked the ability of McN-A-343 to suppress M2-inhibition and A2A-facilitation of [3H]ACh release caused by oxotremorine and CGS 21680C, respectively. Co-application of chelerythrine together with McN-A-343 restored oxotremorine-inhibition and CGS 21680C-facilitation, but this was not observed when the M1 agonist was applied together with LiCl and 2-APB. McN-A-343 also masked facilitation of [3H]ACh release caused by stimulators of the cyclic AMP pathway, forskolin and rolipram. Data suggest that M1-facilitation of ACh release results mainly from activation of the IP3 pathway. This mechanism can be dissociated from the way M1 receptor operates suppression of neuromodulation through M2-inhibitory and A2A-facilitatory receptors, which might involve secondary PKC activation.","PeriodicalId":88702,"journal":{"name":"Signal transduction","volume":"25 3","pages":"19-31"},"PeriodicalIF":0.0000,"publicationDate":"2006-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1002/SITA.200500057","citationCount":"5","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Signal transduction","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1002/SITA.200500057","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 5
Abstract
Acetylcholine (ACh) facilitates its own release acting at muscarinic M1 receptors on rat motoneurons. While the M1 positive feedback mechanism is operative there is a concomitant suppression of the ability of muscarinic M2-inhibitory and adenosine A2A-facilitatory receptors to control [3H]ACh release. We aimed at investigating whether M1-occlusion of M2 and A2A receptors function could result from interplay at second messengers level. Drugs blocking the IP3 pathway, like LiCl and 2-aminoethoxydiphenylborane (2-APB), but not the selective PKC inhibitor, chelerythrine, attenuated M1 facilitation by McN-A-343. PKC activation with phorbol 12-myristate 13-acetate mimicked the ability of McN-A-343 to suppress M2-inhibition and A2A-facilitation of [3H]ACh release caused by oxotremorine and CGS 21680C, respectively. Co-application of chelerythrine together with McN-A-343 restored oxotremorine-inhibition and CGS 21680C-facilitation, but this was not observed when the M1 agonist was applied together with LiCl and 2-APB. McN-A-343 also masked facilitation of [3H]ACh release caused by stimulators of the cyclic AMP pathway, forskolin and rolipram. Data suggest that M1-facilitation of ACh release results mainly from activation of the IP3 pathway. This mechanism can be dissociated from the way M1 receptor operates suppression of neuromodulation through M2-inhibitory and A2A-facilitatory receptors, which might involve secondary PKC activation.